Expanded collaboration with Nationwide Children's Hospital adds new funding and a third therapeutic candidate (CLN-301) to Alcyone's diversified portfolio of precision CNS therapeutics and delivery ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Alcyone Therapeutics hopes to be a standout star and rising goddess in the central nervous system (CNS) treatment landscape. The Massachusetts biotech unveiled itself Wednesday with $23 million in ...
Biogen has given Alcyone Therapeutics a starring role in its drug delivery strategy, paying $85 million to buy the biotech and take control of an implant for getting medicines into the spinal canal.
CAMBRIDGE, Mass. and LOWELL, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Alcyone Therapeutics (Alcyone) have entered into a license and collaboration agreement to develop ...
LOWELL — Alcyone Lifesciences Inc., a biotech startup that moved its headquarters to the Boott Mill last summer, said it has entered into an “exclusive clinical collaboration” with Houston-based ...
LOWELL — Alcyone Lifesciences Inc., a biotech startup that moved its headquarters to the Boott Mill last summer, said it has entered into an “exclusive clinical collaboration” with Houston-based ...
Biogen and Alcyone Therapeutics (Alcyone) have entered into a collaboration and licensing agreement to develop Alcyone’s ThecaFlex DRx System (ThecaFlex) to improve patient experience and access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results